ABAT Human Gene Knockout Kit (CRISPR)
ABAT - human gene knockout kit via CRISPRchange donor?
KN206793G1, ABAT gRNA vector 1 in pCas-Guide vector,
KN206793G2, ABAT gRNA vector 2 in pCas-Guide vector,
donor vector containing Left and right homologous arms and GFP-puro functional cassette.
GE100003, scramble sequence in pCas-Guide vector
|Disclaimer||The kit is designed based on the best knowledge of CRISPR technology. The system has been functionally validated for knocking-in the cassette downstream the native promoter. The efficiency of the knock-out varies due to the nature of the biology and the complexity of the experimental process.|
|RefSeq||NM_000663, NM_001127448, NM_020686, XM_011522400, XM_011522401|
|Synonyms||GABA-AT; GABAT; NPD009|
|Summary||4-aminobutyrate aminotransferase (ABAT) is responsible for catabolism of gamma-aminobutyric acid (GABA), an important, mostly inhibitory neurotransmitter in the central nervous system, into succinic semialdehyde. The active enzyme is a homodimer of 50-kD subunits complexed to pyridoxal-5-phosphate. The protein sequence is over 95% similar to the pig protein. GABA is estimated to be present in nearly one-third of human synapses. ABAT in liver and brain is controlled by 2 codominant alleles with a frequency in a Caucasian population of 0.56 and 0.44. The ABAT deficiency phenotype includes psychomotor retardation, hypotonia, hyperreflexia, lethargy, refractory seizures, and EEG abnormalities. Multiple alternatively spliced transcript variants encoding the same protein isoform have been found for this gene. [provided by RefSeq, Jul 2008].|
|Gene Expression Resources|
"ABAT" in other Product Lines
Related Products (2)
Mouse monoclonal anti-GAPDH antibody, clone 2D9, Loading, clone OTI2D9 (formerly 2D9)
beta Actin Mouse Monoclonal Antibody, Clone OTI1, Loading Control